|1||NCT00886808||Completed||Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema||
||15||All||18 Years and older (Adult, Senior)||NCT00886808||2006-007-01-DME||February 2008||May 2010||June 2010||April 23, 2009||March 22, 2012||
|A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)||
||Other / Industry||
||185||All||18 Years and older (Adult, Senior)||NCT01565148||2010-007-03-DME||iDEAL||February 2012||February 2014||October 2014||March 28, 2012||August 30, 2017||August 30, 2017||
† Study has passed its completion date and status has not been verified in more than two years.